Insight

Nico Gagelmann: Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older

Photo of Nico Gagelmann from vjhemonc.com

Aug 5, 2024, 14:06

Nico Gagelmann: Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older

Nico Gagelmann, shared a post on X:

“Finally out!

Allogeneic hematopoietic cell transplantation for myelofibrosis aged 70 years or older: A study from the German Registry for Stem Cell Transplantation.”

Nico Gagelmann

Source: Nico Gagelmann/X

Authors: Nico Gagelmann, Claudia Schuh, Robert Zeiser, Matthias Stelljes, Wolfgang Bethge, Gerald Wulf, Daniel Teschner, Stefan Klein, Eva Wagner-Drouet, Edgar Jost, Peter Dreger, Sarah Flossdorf, and Nicolaus Kröger.

Nico Gagelmann

Allogeneic Hematopoietic Cell Transplantation cancer Claudia Schuh Daniel Teschner Edgar Jost Eva Wagner-Drouet Gerald Wulf Matthias Stelljes myelofibrosis Nico Gagelmann Nicolaus Kröger OncoDaily Oncology Peter Dreger Robert Zeiser Sarah Flossdorf Stefan Klein Wolfgang Bethge

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage